Trial Profile
The role of the neurotransmitters dopamine and acetylcholine in the interaction of selective attention and working memory.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Aug 2022
Price :
$35
*
At a glance
- Drugs Galantamine (Primary) ; Levodopa (Primary)
- Indications Alzheimer's disease; Parkinson's disease
- Focus Pharmacodynamics
- 31 Jul 2022 Status changed from recruiting to completed.
- 31 May 2012 New trial record